Regeneron Study Site

New Brunswick, New Jersey

We've found

1 trials

at this facility

First in Human (FIH) Study of REGN5458 in Patients With Relapsed or Refractory Multiple Myeloma

Status: Enrolling, Phase I, II
Updated: 12/31/1969

from

New Brunswick, NJ

Use our guide to learn which trials are right for you!